🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Chester B. Whitley

University of Minnesota

ORCID: 0000-0001-8895-6485
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.480Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Persistent bone and joint disease despite current treatments for mucopolysaccharidosis types I, II, and VI: Data from a 10‐year prospective study

Journal of Inherited Metabolic Disease(2023)10.1002/jimd.12598
Top 40%
0.480DataRank
Top 40%13 citations

Ellen B. Fung, Klane K. White, Troy C. Lund, Paul Harmatz, Paul J. Orchard +3 more

Papers

Driven by 12 papers — median percentile 60. Top paper: “Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial”.

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

The Lancet Neurology(2021)10.1016/s1474-4422(21)00241-6
N/A
2.9DataRank · unranked
185 citations

Priya S. Kishnani, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Volker Straub +95 more

Persistent bone and joint disease despite current treatments for mucopolysaccharidosis types I, II, and VI: Data from a 10‐year prospective study

Journal of Inherited Metabolic Disease(2023)10.1002/jimd.12598
Top 40%
0.480DataRank
Top 40%13 citations

Ellen B. Fung, Klane K. White, Troy C. Lund, Paul Harmatz, Paul J. Orchard +3 more

Quantitative brain MRI morphology in severe and attenuated forms of mucopolysaccharidosis type I

Molecular Genetics and Metabolism(2022)10.1016/j.ymgme.2022.01.001
N/A
0.360DataRank · unranked
10 citations

Elsa Shapiro, Kyle Rudser, Bryon A. Mueller, Julie B. Eisengart, Kathleen Delaney +16 more

Contribution of the innate and adaptive immune systems to aortic dilation in murine mucopolysaccharidosis type I

Molecular Genetics and Metabolism(2022)10.1016/j.ymgme.2022.01.104
N/A
0DataRank · unranked
6 citations

Juan E. Abrahante, Ron McElmurry, Michael D. Evans, Miles C. Smith, Davis Seelig +5 more

Mapping brain networks in MPS I mice and their restoration following gene therapy

Scientific Reports(2023)10.1038/s41598-023-39939-0
N/A
0DataRank · unranked
4 citations

Li Ou, Lin Zhang, Isaac Clark, Ying Zhang, Xiaohong Zhu +5 more

Quantitative brain morphometry identifies cerebellar, cortical, and subcortical gray and white matter atrophy in late‐onset Tay‐Sachs disease

Journal of Inherited Metabolic Disease(2023)10.1002/jimd.12700
N/A
0DataRank · unranked
4 citations

Igor Nestrašil, Alia Ahmed, Monica T. Bondy, Jiří Klempíř, Helena Jahnová +11 more

Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS I

Molecular Therapy — Methods & Clinical Development(2024)10.1016/j.omtm.2024.101369
N/A
0DataRank · unranked
4 citations

Avery Huber, Hillary Mantone, Mason Robertson, Miles C. Smith, Andrea D. Karlen +12 more

Diffusion tensor imaging with free‐water correction reveals distinctions between severe and attenuated subtypes in Mucopolysaccharidosis type I

Journal of Inherited Metabolic Disease(2025)10.1002/jimd.12830
N/A
0DataRank · unranked
0 citations

Ofer Pasternak, Julie B. Eisengart, Kyle Rudser, Petr Bednařík, Bryon A. Mueller +5 more

A novel gene editing system to treat both Tay–Sachs and Sandhoff diseases

Gene Therapy(2020)10.1038/s41434-019-0120-5
N/A
0DataRank · unranked
54 citations

Michael J. Przybilla, Alexandru-Flaviu Tăbăran, Paula Overn, M. Gerard O’Sullivan, Xuntian Jiang +5 more

Fabry disease and evolving story of I198T and A143T: Variants of varying clinical consequence (VVCC)

Molecular Genetics and Metabolism(2025)10.1016/j.ymgme.2025.109222
N/A
0DataRank · unranked
0 citations

Sofia Shrestha, Alia Ahmed, Grace McCarthy, Chester B. Whitley, Jeanine R. Jarnes +1 more

The juvenile gangliosidoses: A timeline of clinical change

Molecular Genetics and Metabolism Reports(2020)10.1016/j.ymgmr.2020.100676
N/A
0DataRank · unranked
17 citations

Sarah Kim-McOlash, Chester B. Whitley, Jeanine R. Jarnes-Utz, Kelly King

Biomarkers for prediction of skeletal disease progression in mucopolysaccharidosis type I

JIMD Reports(2020)10.1002/jmd2.12190
N/A
0DataRank · unranked
14 citations

Terence M. Doherty, Julie B. Eisengart, Rebecca Freese, Kyle Rudser, Ellen B. Fung +6 more